AVNS AVANOS MEDICAL, INC.companySEC Filings & Insider Trading Activity 2026
Latest AVANOS MEDICAL, INC. (AVNS) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 24, 2026, a 10-Q quarterly report filed on November 5, 2025, an 8-K current report filed on April 14, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for AVANOS MEDICAL, INC. (AVNS) (SEC CIK 1606498), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 5.02: Departure/Appointment of Directors or Principal Officers
- • CEO David Pacitti's annual LTI grant target raised 10% from $5,000,000 to $5,500,000, effective 2026
- • Increase signals Board confidence in Pacitti's leadership; adds $500K annual equity cost to compensation expense
Item 1.01: Entry into a Material Definitive Agreement
- • Activist investor Bradley Radoff withdrew director nomination in exchange for Board seat for his candidate, James L. Cunniff, at 2026 annual meeting
- • Board also committed to nominate one additional independent director at 2026 annual meeting — net addition of two new board members
Item 8.01: Other Events
- • AVNS reached an agreement with an activist/outside party nominating Mr. Cunniff to the Board at the 2026 Annual Meeting
- • Second independent director nominee William P. Burke also added per the same agreement — signals negotiated board refresh likely under investor pressure
Recent 8-K FilingsCurrent Reports
AI-powered analysis of AVANOS MEDICAL, INC. (AVNS) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 14, 2026 | — | — | — |
8-K | Mar 12, 2026 | — | Analysis | — |
8-K | Feb 26, 2026 | — | Analysis | — |
10-K | Feb 24, 2026 | Dec 31, 2025 | — | |
8-K | Feb 24, 2026 | — | Analysis | — |
8-K | Jan 13, 2026 | — | — | |
8-K | Dec 5, 2025 | — | — | |
10-Q | Nov 5, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 5, 2025 | Jun 30, 2025 | — | |
10-Q | May 6, 2025 | Mar 31, 2025 | — | |
10-K | Feb 26, 2025 | Dec 31, 2024 | — | |
10-Q | Oct 30, 2024 | Sep 30, 2024 | — | |
10-Q | Jul 31, 2024 | Jun 30, 2024 | — | |
10-Q | May 2, 2024 | Mar 31, 2024 | — | |
10-K | Feb 21, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 1, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 9, 2023 | Jun 30, 2023 | — | |
10-Q | May 3, 2023 | Mar 31, 2023 | — | |
10-K | Feb 21, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 2, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 9, 2022 | Jun 30, 2022 | — | |
10-Q | May 4, 2022 | Mar 31, 2022 | — | |
10-K | Feb 23, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 2, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 3, 2021 | Jun 30, 2021 | — |
Frequently Asked Questions
What are the latest AVNS SEC filings in 2026?
AVANOS MEDICAL, INC. (AVNS) has filed a 10-K annual report on February 24, 2026, a 10-Q quarterly report on November 5, 2025, an 8-K current report on April 14, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did AVNS file its most recent 10-K annual report?
AVANOS MEDICAL, INC. (AVNS) filed its most recent 10-K annual report on February 24, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view AVNS 10-Q quarterly reports?
AVANOS MEDICAL, INC. (AVNS)'s most recent 10-Q quarterly report was filed on November 5, 2025. SignalX displays every AVNS 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has AVNS filed recently?
AVANOS MEDICAL, INC. (AVNS)'s most recent 8-K was filed on April 14, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find AVNS insider trading activity (Form 4)?
SignalX aggregates every AVNS Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does AVNS file with the SEC?
AVANOS MEDICAL, INC. (AVNS) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new AVNS filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for AVANOS MEDICAL, INC. (AVNS).
What is AVNS's SEC CIK number?
AVANOS MEDICAL, INC. (AVNS)'s SEC CIK (Central Index Key) number is 1606498. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1606498 to look up all AVNS filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find AVNS return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from AVANOS MEDICAL, INC. (AVNS) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of AVANOS MEDICAL, INC. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 52+ filings.